Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunity, inflammation, and cancer.

Literature DB >> 20303878

Immunity, inflammation, and cancer.

Sergei I Grivennikov¹, Florian R Greten, Michael Karin.

Abstract

Inflammatory responses play decisive roles at different stages of tumor development, including initiation, promotion, malignant conversion, invasion, and metastasis. Inflammation also affects immune surveillance and responses to therapy. Immune cells that infiltrate tumors engage in an extensive and dynamic crosstalk with cancer cells, and some of the molecular events that mediate this dialog have been revealed. This review outlines the principal mechanisms that govern the effects of inflammation and immunity on tumor development and discusses attractive new targets for cancer therapy and prevention. 2010 Elsevier Inc. All rights reserved.

Entities: Chemical Disease Gene Species

Mesh：

Year: 2010 PMID： 20303878 PMCID： PMC2866629 DOI： 10.1016/j.cell.2010.01.025

Source DB: PubMed Journal: Cell ISSN： 0092-8674 Impact factor: 41.582

157 in total

1. Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion.

Authors: J Khasawneh; M D Schulz; A Walch; J Rozman; M Hrabe de Angelis; M Klingenspor; A Buck; M Schwaiger; D Saur; R M Schmid; G Klöppel; B Sipos; F R Greten; M C Arkan
Journal: Proc Natl Acad Sci U S A Date: 2009-02-10 Impact factor: 11.205

Review 2. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe.

Authors: Bharat B Aggarwal; R V Vijayalekshmi; Bokyung Sung
Journal: Clin Cancer Res Date: 2009-01-15 Impact factor: 12.531

3. A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations.

Authors: A Takai; T Toyoshima; M Uemura; Y Kitawaki; H Marusawa; H Hiai; S Yamada; I M Okazaki; T Honjo; T Chiba; K Kinoshita
Journal: Oncogene Date: 2008-11-10 Impact factor: 9.867

4. Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment.

Authors: Marcin Kortylewski; Hong Xin; Maciej Kujawski; Heehyoung Lee; Yong Liu; Timothy Harris; Charles Drake; Drew Pardoll; Hua Yu
Journal: Cancer Cell Date: 2009-02-03 Impact factor: 31.743

5. Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component.

Authors: John A Lust; Martha Q Lacy; Steven R Zeldenrust; Angela Dispenzieri; Morie A Gertz; Thomas E Witzig; Shaji Kumar; Suzanne R Hayman; Stephen J Russell; Francis K Buadi; Susan M Geyer; Megan E Campbell; Robert A Kyle; S Vincent Rajkumar; Philip R Greipp; Michael P Kline; Yuning Xiong; Laurie L Moon-Tasson; Kathleen A Donovan
Journal: Mayo Clin Proc Date: 2009-02 Impact factor: 7.616

6. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.

Authors: Julia Bollrath; Toby J Phesse; Vivian A von Burstin; Tracy Putoczki; Moritz Bennecke; Trudie Bateman; Tim Nebelsiek; Therese Lundgren-May; Ozge Canli; Sarah Schwitalla; Vance Matthews; Roland M Schmid; Thomas Kirchner; Melek C Arkan; Matthias Ernst; Florian R Greten
Journal: Cancer Cell Date: 2009-02-03 Impact factor: 31.743

7. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors: Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal: Cancer Cell Date: 2009-02-03 Impact factor: 31.743

8. The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling.

Authors: L Lin; R Amin; G I Gallicano; E Glasgow; W Jogunoori; J M Jessup; M Zasloff; J L Marshall; K Shetty; L Johnson; L Mishra; A R He
Journal: Oncogene Date: 2009-01-12 Impact factor: 9.867

Review 9. Myeloid-derived suppressor cells as regulators of the immune system.

Authors: Dmitry I Gabrilovich; Srinivas Nagaraj
Journal: Nat Rev Immunol Date: 2009-03 Impact factor: 53.106

Review 10. Concepts of epigenetics in prostate cancer development.

Authors: C S Cooper; C S Foster
Journal: Br J Cancer Date: 2008-11-11 Impact factor: 7.640

2000 in total

1. The prognostic role of preoperative circulating neutrophil-lymphocyte ratio in primary bladder cancer patients undergoing radical cystectomy: a meta-analysis.

Authors: Guoming Hu; Feng Xu; Kefang Zhong; Shimin Wang; Qi Xu; Liming Huang; Pu Cheng
Journal: World J Urol Date: 2018-12-03 Impact factor: 4.226

2. Epithelial cell proliferation in the developing zebrafish intestine is regulated by the Wnt pathway and microbial signaling via Myd88.

Authors: Sarah E Cheesman; James T Neal; Erika Mittge; Barbara M Seredick; Karen Guillemin
Journal: Proc Natl Acad Sci U S A Date: 2010-10-04 Impact factor: 11.205

3. A comparison between the effects of ochratoxin A and aristolochic acid on the inflammation and oxidative stress in the liver and kidney of weanling piglets.

Authors: D E Marin; G C Pistol; M Gras; M Palade; I Taranu
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2018-07-22 Impact factor: 3.000

4. Angiopoietin-like protein 2 facilitates non-small cell lung cancer progression by promoting the polarization of M2 tumor-associated macrophages.

Authors: Xiaojuan Wei; Siyue Nie; Hui Liu; Jingyu Sun; Jie Liu; Juan Li; Shuyan Li; Shuyun Wang; Shuyi Han; Jun Wang; Yuping Sun
Journal: Am J Cancer Res Date: 2017-11-01 Impact factor: 6.166

Review 5. Therapeutic dormancy to delay postsurgical glioma recurrence: the past, present and promise of focal hypothermia.

Authors: Didier Wion
Journal: J Neurooncol Date: 2017-05-17 Impact factor: 4.130

6. Immune chaperone gp96 drives the contributions of macrophages to inflammatory colon tumorigenesis.

Authors: Crystal Morales; Saleh Rachidi; Feng Hong; Shaoli Sun; Xinshou Ouyang; Caroline Wallace; Yongliang Zhang; Elizabeth Garret-Mayer; Jennifer Wu; Bei Liu; Zihai Li
Journal: Cancer Res Date: 2013-12-09 Impact factor: 12.701

7. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth.

Authors: Sergei I Grivennikov; Kepeng Wang; Daniel Mucida; C Andrew Stewart; Bernd Schnabl; Dominik Jauch; Koji Taniguchi; Guann-Yi Yu; Christoph H Osterreicher; Kenneth E Hung; Christian Datz; Ying Feng; Eric R Fearon; Mohamed Oukka; Lino Tessarollo; Vincenzo Coppola; Felix Yarovinsky; Hilde Cheroutre; Lars Eckmann; Giorgio Trinchieri; Michael Karin
Journal: Nature Date: 2012-11-08 Impact factor: 49.962

8. Transgenic expression of interferon-γ in mouse stomach leads to inflammation, metaplasia, and dysplasia.

Authors: Li-Jyun Syu; Mohamad El-Zaatari; Kathryn A Eaton; Zhiping Liu; Manas Tetarbe; Theresa M Keeley; Joanna Pero; Jennifer Ferris; Dawn Wilbert; Ashley Kaatz; Xinlei Zheng; Xiotan Qiao; Marina Grachtchouk; Deborah L Gumucio; Juanita L Merchant; Linda C Samuelson; Andrzej A Dlugosz
Journal: Am J Pathol Date: 2012-10-01 Impact factor: 4.307

Review 9. Role of inflammasome activation in tumor immunity triggered by immune checkpoint blockers.

Authors: M Segovia; S Russo; M R Girotti; G A Rabinovich; M Hill
Journal: Clin Exp Immunol Date: 2020-05 Impact factor: 4.330

10. Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis.

Authors: Joanne R Doherty; Chunying Yang; Kristen E N Scott; Michael D Cameron; Mohammad Fallahi; Weimin Li; Mark A Hall; Antonio L Amelio; Jitendra K Mishra; Fangzheng Li; Mariola Tortosa; Heide Marika Genau; Robert J Rounbehler; Yunqi Lu; Chi V Dang; K Ganesh Kumar; Andrew A Butler; Thomas D Bannister; Andrea T Hooper; Keziban Unsal-Kacmaz; William R Roush; John L Cleveland
Journal: Cancer Res Date: 2013-11-27 Impact factor: 12.701